57 related articles for article (PubMed ID: 5488205)
1. Drug dosage in patients with impaired renal function.
Dettli L; Spring P; Habersang R
Postgrad Med J; 1970 Oct; ():Suppl:32-5. PubMed ID: 5488205
[No Abstract] [Full Text] [Related]
2. Emerging Roles of Aryl Hydrocarbon Receptors in the Altered Clearance of Drugs during Chronic Kidney Disease.
Santana Machado T; Cerini C; Burtey S
Toxins (Basel); 2019 Apr; 11(4):. PubMed ID: 30959953
[TBL] [Abstract][Full Text] [Related]
3. Does Secretory Clearance Follow Glomerular Filtration Rate in Chronic Kidney Diseases? Reconsidering the Intact Nephron Hypothesis.
Chapron A; Shen DD; Kestenbaum BR; Robinson-Cohen C; Himmelfarb J; Yeung CK
Clin Transl Sci; 2017 Sep; 10(5):395-403. PubMed ID: 28675584
[TBL] [Abstract][Full Text] [Related]
4. A Synopsis of Clinical Pharmacokinetic Alterations in Advanced CKD.
Nolin TD
Semin Dial; 2015; 28(4):325-9. PubMed ID: 25855244
[TBL] [Abstract][Full Text] [Related]
5. Prescribing aids for gentamicin.
Mawer GE; Ahmad R; Dobbs SM; McGough JG; Lucas SB; Tooth JA
Br J Clin Pharmacol; 1974 Feb; 1(1):45-50. PubMed ID: 22454868
[TBL] [Abstract][Full Text] [Related]
6. Early research on renal function and drug action.
Reidenberg MM
J Clin Pharmacol; 2012 Jan; 52(1 Suppl):7S-9S. PubMed ID: 22232758
[TBL] [Abstract][Full Text] [Related]
7. Drug dosage in end-stage renal disease (ESRD) patients undergoing haemodialysis. A predictive study based on a microcomputer program.
Mac-Kay MV; Sanchez Burson J; Martinez-Lanao J; Dominguez-Gil A
Clin Pharmacokinet; 1993 Sep; 25(3):243-57. PubMed ID: 8222463
[TBL] [Abstract][Full Text] [Related]
8. The effect of impaired renal function on the plasma concentration and urinary excretion of metoprolol metabolites.
Hoffmann KJ; Regårdh CG; Aurell M; Ervik M; Jordö L
Clin Pharmacokinet; 1980; 5(2):181-91. PubMed ID: 7363533
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics of nortriptyline in patients with chronic renal failure.
Dawlilng S; Lynn K; Rosser R; Braithwaite R
Br J Clin Pharmacol; 1981 Jul; 12(1):39-45. PubMed ID: 7248140
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of metioprim in normal subjects and patients with impaired renal function.
Vergin H; Bishop-Freudling GB; Kaiser W; Köhler M; Strobel K; Reutter FW
Antimicrob Agents Chemother; 1983 Aug; 24(2):190-3. PubMed ID: 6638987
[TBL] [Abstract][Full Text] [Related]
11. Formal theory of discrete drug dosing regimen adjustments.
Janků I
Eur J Clin Pharmacol; 1983; 25(1):123-30. PubMed ID: 6617714
[No Abstract] [Full Text] [Related]
12. Differences in kinetic properties of drugs: implications as to the selection of a particular drug for use in patients with renal failure with special emphasis on antibiotics and beta-adrenoceptor blocking agents.
Fabre J; Fox HM; Dayer P; Balant L
Clin Pharmacokinet; 1980; 5(5):441-64. PubMed ID: 6105934
[TBL] [Abstract][Full Text] [Related]
13. Translation of pharmacokinetics to clinical medicine.
Dettli L
J Pharmacokinet Biopharm; 1973 Oct; 1(5):403-18. PubMed ID: 4787617
[No Abstract] [Full Text] [Related]
14. Proceedings: Digoxin dosage in patients with impaired kidney function.
Dettli L; Ohnhaus EE; Spring P
Br J Pharmacol; 1972 Feb; 44(2):373P. PubMed ID: 4668631
[No Abstract] [Full Text] [Related]
15. Cephalexin: a review of its antibacterial, pharmacological and therapeutic properties.
Speight TM; Brogden RN; Avery GS
Drugs; 1972; 3(1):9-78. PubMed ID: 4559812
[No Abstract] [Full Text] [Related]
16. Pitfalls of pharmacokinetic dosage guidelines in renal insufficiency.
Turnheim K
Eur J Clin Pharmacol; 1991; 40(1):87-93. PubMed ID: 2060552
[TBL] [Abstract][Full Text] [Related]
17. Individualising gentamicin dosage regimens. A comparative review of selected models, data fitting methods and monitoring strategies.
Jelliffe RW; Iglesias T; Hurst AK; Foo KA; Rodriguez J
Clin Pharmacokinet; 1991 Dec; 21(6):461-78. PubMed ID: 1782740
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics in the elderly.
Triggs EJ; Nation RL; Long A; Ashley JJ
Eur J Clin Pharmacol; 1975; 8(1):55-62. PubMed ID: 1233203
[TBL] [Abstract][Full Text] [Related]
19. Treatment with sisomicin of complicated urinary tract infections in patients with varying degrees of renal function impairment, pharmacokinetics and dosage adjustment.
Mosegaard A; Welling PG; Tse FL; Madsen P
Infection; 1975; 3(3):143-7. PubMed ID: 1223005
[TBL] [Abstract][Full Text] [Related]
20. Elimination kinetics of sulfadiazine in patients with normal and impaired renal function.
Ohnhaus EE; Spring P
J Pharmacokinet Biopharm; 1975 Jun; 3(3):171-9. PubMed ID: 1159621
[No Abstract] [Full Text] [Related]
[Next] [New Search]
